| Revision of the American Joint Committee on Cancer staging system for breast cancer SE Singletary, C Allred, P Ashley, LW Bassett, D Berry, KI Bland, ... Journal of clinical oncology 20 (17), 3628-3636, 2002 | 1800 | 2002 |
| Prognostic factors in breast cancer: College of American Pathologists consensus statement 1999 PL Fitzgibbons, DL Page, D Weaver, AD Thor, DC Allred, GM Clark, ... Archives of pathology & laboratory medicine 124 (7), 966-978, 2000 | 1792 | 2000 |
| Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells Z Zou, A Anisowicz, MJC Hendrix, A Thor, M Neveu, S Sheng, K Rafidi, ... Science 263 (5146), 526-529, 1994 | 1312 | 1994 |
| c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer HB Muss, AD Thor, DA Berry, T Kute, ET Liu, F Koerner, CT Cirrincione, ... New England Journal of Medicine 330 (18), 1260-1266, 1994 | 1284 | 1994 |
| Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers AD Thor, DH Moore, SM Edgerton, ES Kawasaki, E Reihsaus, HT Lynch, ... JNCI: Journal of the National Cancer Institute 84 (11), 845-855, 1992 | 931 | 1992 |
| erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer AD Thor, DA Berry, DR Budman, HB Muss, T Kute, IC Henderson, ... JNCI: Journal of the National Cancer Institute 90 (18), 1346-1360, 1998 | 779 | 1998 |
| ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. OP Kallioniemi, A Kallioniemi, W Kurisu, A Thor, LC Chen, HS Smith, ... Proceedings of the National Academy of Sciences 89 (12), 5321-5325, 1992 | 751 | 1992 |
| HER2 and response to paclitaxel in node-positive breast cancer DF Hayes, AD Thor, LG Dressler, D Weaver, S Edgerton, D Cowan, ... New England Journal of Medicine 357 (15), 1496-1506, 2007 | 722 | 2007 |
| Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with … BP Schneider, M Wang, M Radovich, GW Sledge, S Badve, A Thor, ... Journal of Clinical Oncology 26 (28), 4672, 2008 | 719 | 2008 |
| Loss of heterozygosity in normal tissue adjacent to breast carcinomas G Deng, Y Lu, G Zlotnikov, AD Thor, HS Smith Science 274 (5295), 2057-2059, 1996 | 712 | 1996 |
| Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro IN Alimova, B Liu, Z Fan, SM Edgerton, T Dillon, SE Lind, AD Thor Cell cycle 8 (6), 909-915, 2009 | 641 | 2009 |
| Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72. 3 A Thor, N Ohuchi, CA Szpak, WW Johnston, J Schlom Cancer research 46 (6), 3118-3124, 1986 | 593 | 1986 |
| Metformin induces unique biological and molecular responses in triple negative breast cancer cells B Liu, Z Fan, SM Edgerton, XS Deng, IN Alimova, SE Lind, AD Thor Cell cycle 8 (13), 2031-2040, 2009 | 519 | 2009 |
| Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide DR Cochrane, S Bernales, BM Jacobsen, DM Cittelly, EN Howe, ... Breast Cancer Research 16, 1-19, 2014 | 440 | 2014 |
| Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin-and etoposide-induced apoptosis XH Yang, TL Sladek, X Liu, BR Butler, CJ Froelich, AD Thor Cancer research 61 (1), 348-354, 2001 | 402 | 2001 |
| Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual SE Singletary, C Allred, P Ashley, LW Bassett, D Berry, KI Bland, ... Surgical Clinics 83 (4), 803-819, 2003 | 394 | 2003 |
| p53 gene mutations and protein accumulation in human ovarian cancer. J Kupryjańczyk, AD Thor, R Beauchamp, V Merritt, SM Edgerton, DA Bell, ... Proceedings of the National Academy of Sciences 90 (11), 4961-4965, 1993 | 391 | 1993 |
| Expression of ras Oncogene p21 in Prostate Cancer MV Viola, F Fromowitz, S Oravez, S Deb, G Finkel, J Lundy, P Hand, ... New England Journal of Medicine 314 (3), 133-137, 1986 | 355 | 1986 |
| Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma VL Cryns, A Thor, HJ Xu, SX Hu, ME Wierman, AL Vickery Jr, WF Benedict, ... New England Journal of Medicine 330 (11), 757-761, 1994 | 353 | 1994 |
| Survival signaling by Notch1: mammalian target of rapamycin (mTOR)–dependent inhibition of p53 SK Mungamuri, XH Yang, AD Thor, K Somasundaram Cancer research 66 (9), 4715-4724, 2006 | 329 | 2006 |
